^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
HB0045
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Zhejiang Huahai Pharma
Drug class:
CD73 inhibitor
Related drugs:
Phase 1/2
Shanghai Huaota Biopharmaceutical Co., Ltd.
Recruiting
Last update posted :
10/20/2023
Initiation :
07/18/2023
Primary completion :
09/19/2025
Completion :
03/19/2026
MSI • CD4
|
HB0045
Phase 1/2
Huabo Biopharm Co., Ltd.
Not yet recruiting
Last update posted :
07/13/2023
Initiation :
08/20/2023
Primary completion :
08/19/2025
Completion :
03/19/2026
MSI • CD4
|
HB0045
Share
